7.67
前日終値:
$7.70
開ける:
$7.76
24時間の取引高:
12.91M
Relative Volume:
3.49
時価総額:
$2.97B
収益:
$1.42B
当期純損益:
$9.66M
株価収益率:
306.80
EPS:
0.025
ネットキャッシュフロー:
$110.03M
1週間 パフォーマンス:
+5.50%
1か月 パフォーマンス:
+19.84%
6か月 パフォーマンス:
+18.55%
1年 パフォーマンス:
+33.86%
Lifestance Health Group Inc Stock (LFST) Company Profile
名前
Lifestance Health Group Inc
セクター
電話
602-767-2100
住所
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Compare LFST vs HCA, THC, DVA, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LFST
Lifestance Health Group Inc
|
7.67 | 2.99B | 1.42B | 9.66M | 110.03M | 0.025 |
|
HCA
Hca Healthcare Inc
|
426.37 | 96.54B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
191.68 | 16.40B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
198.93 | 12.75B | 13.64B | 1.05B | 1.31B | 9.555 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.76 | 11.83B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
EHC
Encompass Health Corp
|
104.82 | 10.53B | 6.07B | 793.80M | 464.40M | 5.9914 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-07-25 | 開始されました | BTIG Research | Buy |
| 2025-05-27 | アップグレード | UBS | Neutral → Buy |
| 2025-04-08 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-04-03 | 開始されました | Canaccord Genuity | Buy |
| 2024-12-16 | アップグレード | Goldman | Neutral → Buy |
| 2024-01-03 | 開始されました | Barclays | Underweight |
| 2023-05-15 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-01-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-07 | 再開されました | Jefferies | Buy |
| 2022-03-17 | ダウングレード | UBS | Buy → Neutral |
| 2021-11-09 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-09-10 | 開始されました | Cowen | Outperform |
| 2021-08-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-06 | 開始されました | Goldman | Neutral |
| 2021-07-06 | 開始されました | JP Morgan | Overweight |
| 2021-07-06 | 開始されました | Jefferies | Buy |
| 2021-07-06 | 開始されました | Morgan Stanley | Overweight |
| 2021-07-06 | 開始されました | William Blair | Outperform |
すべてを表示
Lifestance Health Group Inc (LFST) 最新ニュース
LFST Q1 Deep Dive: Technology and Clinician Productivity Drive Outperformance and Guidance Increase - Yahoo Finance
LifeStance Health director Robert Bessler sells $641,250 in shares By Investing.com - Investing.com Australia
LifeStance Health director Robert Bessler sells $641,250 in shares - Investing.com
75K LifeStance (NASDAQ: LFST) shares sold by director-linked entities - Stock Titan
LifeStance Health Group prices secondary offering at $8.15 per share - MSN
LifeStance Health Group, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LFST) 2026-05-10 - Seeking Alpha
LFST Drops As LifeStance Secondary Offering Hits Market - timothysykes.com
LifeStance Health Stock Slides After $8.15 Secondary Pricing - timothysykes.com
Summit holds 29.2M LifeStance shares (NASDAQ: LFST) in Schedule 13G/A - Stock Titan
[424B7] LifeStance Health Group, Inc. Prospectus Filed Pursuant to Rule 424(b)(7) - Stock Titan
LifeStance Health Group (LFST) Stock Trades Down, Here Is Why - StockStory
LifeStance Health LFST Slides As 35M-Share Secondary Hits Market - StocksToTrade
LFST Stock Slips As 35M-Share Secondary Tests Market Demand - timothysykes.com
LFST Stock Slips As 35M-Share Secondary Tests Demand - StocksToTrade
35M-share resale by LifeStance (NASDAQ: LFST) with 6M-share repurchase - Stock Titan
LFST Stock Pressured As 35M-Share Secondary Hits Market - timothysykes.com
LifeStance Health stock tumbles on secondary offering pricing By Investing.com - Investing.com Australia
LifeStance Health stock tumbles on secondary offering pricing - Investing.com
LifeStance Q1 2026 presentation: 21% revenue growth, guidance raised By Investing.com - Investing.com Canada
Lifestance Health Group stock hits 52-week high at $8.11 By Investing.com - Investing.com Canada
Why Lifestance Health Group Shares Are Sliding - TipRanks
MSN Money - MSN
Latest LFST NewsLifeStance Health Announces Second Quarter ... - Stock Titan
LifeStance Health Group (LFST) Earnings Date and Reports 2026 $LFST - MarketBeat
LifeStance Health Group Q1 Earnings Call Highlights - Yahoo Finance
LifeStance Agreed to Purchase 6M Shrs From Underwriter of Offering >LFST - Moomoo
LifeStance Health prices secondary offering at $8.15 per share - Investing.com
LifeStance (LFST) Hits 2-Year High as Q1 Profits Soar 1,900% - Insider Monkey
LifeStance Health Lifts Outlook on Profitable Q1 - TipRanks
LifeStance Health prices secondary offering at $8.15 per share By Investing.com - Investing.com Australia
Why LifeStance Health Group zoomed 20% higher today - MSN
Lifestance Health Group announces pricing of secondary public offering - marketscreener.com
Lifestance Health Group Announces Pricing Of Secondary Public Offering - TradingView
LifeStance shareholders launch 35 million-share secondary offering - MSN
LifeStance Health Group Q1 2026 Earnings Call Transcript - MarketBeat
LifeStance stockholders plan 35M share offering - Investing.com UK
Why LifeStance Health Group Zoomed 20% Higher Today - AOL.com
LifeStance Health Group, Inc. Stock 12‑Month Price Target Raised to $9.94, Implies 35% Upside - TradingView
LifeStance Health Group (LFST) Eps Diluted (TTM) - Zacks Investment Research
LifeStance stockholders plan 35M share offering By Investing.com - Investing.com Australia
LifeStance Health Group Announces Launch of Secondary Public Offering - The Manila Times
LifeStance Health Group, Inc. Announces Stockholder Offering of 35 Million Shares and Concurrent Repurchase of 6 Million Shares - Quiver Quantitative
LifeStance Health Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
LifeStance holders offer 35M shares; company plans 6M buyback - Stock Titan
75,000-share Form 144 filing by LifeStance Health (NASDAQ: LFST) - Stock Titan
LifeStance Health Group, Inc. 1Q 2026: Revenue $403.5M, EPS $0.04— 10-Q Summary - TradingView
LifeStance (NASDAQ: LFST) posts Q1 2026 revenue of $403,476 - Stock Titan
LifeStance CEO Says M&A Tuck-In Deals, De Novos Are Back on the Table - Behavioral Health Business
Why Is LifeStance Health Group (LFST) Stock Rocketing Higher Today - StockStory
Lifestance forecasts $1.64B-$1.68B 2026 revenue while targeting mid-teens adjusted EBITDA margins by 2028 - MSN
LifeStance Q1 2026 presentation: 21% revenue growth, guidance raised - Investing.com
Lifestance Health Group Inc (LFST) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):